CQT.AU Conneqt Health Limited
- Market cap
- AUD 8.13M
- P/E
- -
- P/B
- 2.75x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- 0.2/5
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Dec 2025.
Is CQT.AU undervalued?
Graham numberThe Graham number of Conneqt Health Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Conneqt Health Limited fundamental analysis
1 of 21 checks passedROE 0/2
ROE cannot be calculated: equity is negative or not reported.
ROA 0/1
Return on assets (-305.1%) is below the industry median (-7.4%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-47.1%) is below the industry median (5.2%).
Revenue Growth 0/2
Revenue shrank 4.4% a year over the past 3 years.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 0/2
Cash runway cannot be calculated.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (2.8x) is above the industry median (2.5x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Conneqt Health Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Conneqt Health Limited
CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biomarker platform that captures a peripheral arterial waveform from the upper-arm, wrist, or finger and convert it to a central pressure waveform to extract vascular biomarkers. The company also provides medical and home health care devices and digital solutions fo…
Full company profileConneqt Health Limited financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 1 quarter up to Dec 31, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
Conneqt Health Limited annual financial statements
| Item | 2022 | 2023 | 2024 | 2025 | 2025 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 4.07M | 4.86M | 11.2M | 3.55M | 9.14M |
| Gross Profit | 3.06M | 3.96M | 10.4M | 2.56M | 6.53M |
| Operating Income | -12.9M | -15.1M | -4.36M | -12.8M | -23.1M |
| EBITDA | -11.4M | -18.3M | -5.35M | - | - |
| Net Income | -11.8M | -18.9M | -6.77M | -18.2M | -24.0M |
| EPS | -0.09 | -0.12 | -0.02 | -0.03 | -0.04 |
| Balance Sheet | |||||
| Total Assets | 12.4M | 14.5M | 12.6M | 9.32M | 7.86M |
| Total Liabilities | 5.77M | 15.3M | 8.56M | 8.69M | 10.3M |
| Shareholders' Equity | 6.61M | -748K | 4.09M | 634K | -2.46M |
| Cash & Short-term Investments | 1.46M | 716K | 481K | 2.43M | 2.43M |
| Cash Flow | |||||
| Operating Cash Flow | - | -12.0M | -7.72M | -10.9M | -18.1M |
| Capital Expenditure | 438K | 80.3K | 118K | 26.3K | 36.2K |
| Free Cash Flow | -9.59M | -12.1M | -7.84M | - | - |
| Ratios | |||||
| ROE | -178.6% | - | -165.5% | -2,871.9% | - |
| ROA | -95.4% | -129.9% | -53.5% | -195.1% | -305.1% |
| Net Profit Margin | -290.4% | -388.5% | -60.5% | -511.9% | -262.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Conneqt Health Limited dividends
Conneqt Health Limited has not paid dividends in the last 6 fiscal years.
Last stock split: 1:10 on Feb 18, 2022.
Who owns Conneqt Health Limited
- Insiders 59.17%
- Institutions 0.00%
- Public & others 40.83%
- Shares outstanding 1.02B
- Free float 377M
Conneqt Health Limited company profile
- Company name
- Conneqt Health Limited
- Ticker
- CQT.AU
- ISIN
- AU0000420739
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Fiscal year end
- June
- Address
- 55 Lime Street, Sydney, NSW, Australia, 2000
- Phone
- 61 2 9874 8761
- Website
- conneqthealth.com
About Conneqt Health Limited
CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biomarker platform that captures a peripheral arterial waveform from the upper-arm, wrist, or finger and convert it to a central pressure waveform to extract vascular biomarkers. The company also provides medical and home health care devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders. It sells its cardiovascular devices and services to individuals, hospitals, clinics, research institutions and pharmaceutical companies. The company was formerly known as CardieX Limited and changed its name to CONNEQT Health Limited in September 2025. CONNEQT Health Limited was founded in 1994 and is based in Sydney, Australia.
Conneqt Health Limited management
6- Mr. Niall Charles Edgar Cairns ACA, B.Ec, FAICDCo-Founder & Executive Chairman · born 1964
- Mr. Craig R. Cooper BEC, L.L.B.Co-Founder, Group CEO, MD & Executive Director · born 1963
- Mr. Douglas T. KurschinskiExecutive VP & Head of Global Sales for AtCor Medical Division
- Ms. Catherine LiaoChief Strategy & Commercial Officer · born 1979
- Mr. Oliver ShayChief Digital Officer
- Ms. Louisa HoCompany Secretary